Understanding how U2AF1 mutations contribute to myelodysplastic syndrome
Distinct roles of U2AF1 mutations in myelodysplastic syndrome pathogenesis
This study is looking into how changes in the U2AF1 gene affect people with myelodysplastic syndrome (MDS), which could help us find better ways to diagnose and treat this blood disorder.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10873169 on NIH RePORTER |
What this research studies
This research investigates the specific roles of U2AF1 mutations in the development of myelodysplastic syndrome (MDS), a type of blood disorder. The project aims to clarify how different mutations in the U2AF1 gene affect the disease's progression and patient outcomes. By utilizing advanced laboratory techniques and collaborating with experts in the field, the research seeks to uncover the molecular mechanisms behind these mutations. This could lead to better diagnostic and therapeutic strategies for patients with MDS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myelodysplastic syndrome, particularly those with U2AF1 mutations.
Not a fit: Patients without myelodysplastic syndrome or those not carrying U2AF1 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with myelodysplastic syndrome.
How similar studies have performed: Previous research has shown promising results in understanding the role of genetic mutations in blood disorders, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Alberti, Michael O — University of Colorado Denver
- Study coordinator: Alberti, Michael O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.